Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer.

Beyer S, Zhu J, Mayr D, Kuhn C, Schulze S, Hofmann S, Dannecker C, Jeschke U, Kost BP.

Int J Mol Sci. 2017 Feb 23;18(3). pii: E477. doi: 10.3390/ijms18030477.

2.

RXRα is upregulated in first trimester endometrial glands of spontaneous abortions unlike LXR and PPARγ.

Knabl J, Vattai A, Hüttenbrenner R, Hutter S, Karsten M, Jeschke U.

Eur J Histochem. 2016 Nov 2;60(4):2665. doi: 10.4081/ejh.2016.2665.

3.
4.

Effects of Phytoestrogen Extracts Isolated from Elder Flower on Hormone Production and Receptor Expression of Trophoblast Tumor Cells JEG-3 and BeWo, as well as MCF7 Breast Cancer Cells.

Schröder L, Richter DU, Piechulla B, Chrobak M, Kuhn C, Schulze S, Abarzua S, Jeschke U, Weissenbacher T.

Nutrients. 2016 Oct 8;8(10). pii: E616.

5.

Influence of VEGFR and LHCGR on endometrial adenocarcinoma.

Kölbl AC, Birk AE, Kuhn C, Jeschke U, Andergassen U.

Oncol Lett. 2016 Sep;12(3):2092-2098. Epub 2016 Jul 22.

6.

The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells.

Kölbl AC, Jeschke U, Andergassen U.

Int J Mol Sci. 2016 Aug 11;17(8). pii: E1308. doi: 10.3390/ijms17081308. Review.

7.

Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment.

Vilsmaier T, Rack B, Janni W, Jeschke U, Weissenbacher T; SUCCESS Study Group..

BMC Cancer. 2016 Jul 27;16:547. doi: 10.1186/s12885-016-2612-7.

8.

Do signal transduction cascades influence survival in triple-negative breast cancer? A preliminary study.

Mumm JN, Kölbl AC, Jeschke U, Andergassen U.

Onco Targets Ther. 2016 May 26;9:3163-9. doi: 10.2147/OTT.S101677. eCollection 2016.

9.

Prototype and Chimera-Type Galectins in Placentas with Spontaneous and Recurrent Miscarriages.

Unverdorben L, Haufe T, Santoso L, Hofmann S, Jeschke U, Hutter S.

Int J Mol Sci. 2016 Apr 28;17(5). pii: E644. doi: 10.3390/ijms17050644.

10.

Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR).

Hutter S, Knabl J, Andergassen U, Hofmann S, Kuhn C, Mahner S, Arck P, Jeschke U.

Int J Mol Sci. 2016 Apr 7;17(4):523. doi: 10.3390/ijms17040523.

11.

Unique trophoblast stem cell- and pluripotency marker staining patterns depending on gestational age and placenta-associated pregnancy complications.

Weber M, Göhner C, San Martin S, Vattai A, Hutter S, Parraga M, Jeschke U, Schleussner E, Markert UR, Fitzgerald JS.

Cell Adh Migr. 2016 Mar 3;10(1-2):56-65. doi: 10.1080/19336918.2016.1142035. Epub 2016 Feb 25.

12.

Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer.

Jäger BA, Finkenzeller C, Bock C, Majunke L, Jueckstock JK, Andergassen U, Neugebauer JK, Pestka A, Friedl TW, Jeschke U, Janni W, Doisneau-Sixou SF, Rack BK.

Transl Oncol. 2015 Dec;8(6):509-16. doi: 10.1016/j.tranon.2015.11.009.

13.

Genotoxicity of Superparamagnetic Iron Oxide Nanoparticles in Granulosa Cells.

Pöttler M, Staicu A, Zaloga J, Unterweger H, Weigel B, Schreiber E, Hofmann S, Wiest I, Jeschke U, Alexiou C, Janko C.

Int J Mol Sci. 2015 Nov 3;16(11):26280-90. doi: 10.3390/ijms161125960.

14.

The Role of Glycosylation in Breast Cancer Metastasis and Cancer Control.

Kölbl AC, Andergassen U, Jeschke U.

Front Oncol. 2015 Oct 13;5:219. doi: 10.3389/fonc.2015.00219. eCollection 2015. Review.

15.

Gal-1 silenced trophoblast tumor cells (BeWo) show decreased syncytium formation and different miRNA production compared to non-target silenced BeWo cells.

Hutter S, Morales-Prieto DM, Andergassen U, Tschakert L, Kuhn C, Hofmann S, Markert UR, Jeschke U.

Cell Adh Migr. 2016 Mar 3;10(1-2):28-38. doi: 10.1080/19336918.2015.1089377. Epub 2015 Sep 29.

16.

Glycosyltransferases as Markers for Early Tumorigenesis.

Andergassen U, Liesche F, Kölbl AC, Ilmer M, Hutter S, Friese K, Jeschke U.

Biomed Res Int. 2015;2015:792672. doi: 10.1155/2015/792672. Epub 2015 Jun 16.

17.

Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.

Heublein S, Mayr D, Meindl A, Angele M, Gallwas J, Jeschke U, Ditsch N.

PLoS One. 2015 Jun 1;10(6):e0127072. doi: 10.1371/journal.pone.0127072. eCollection 2015.

18.

Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.

Heublein S, Mayr D, Egger M, Karsten U, Goletz S, Angele M, Gallwas J, Jeschke U, Ditsch N.

J Exp Clin Cancer Res. 2015 May 19;34:50. doi: 10.1186/s13046-015-0152-7.

19.

Galectin-1 overexpression in endometriosis and its regulation by neuropeptides (CRH, UCN) indicating its important role in reproduction and inflammation.

Vergetaki A, Jeschke U, Vrekoussis T, Taliouri E, Sabatini L, Papakonstanti EA, Makrigiannakis A.

PLoS One. 2014 Dec 4;9(12):e114229. doi: 10.1371/journal.pone.0114229. eCollection 2014.

20.

The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumors.

Heublein S, Mayr D, Friese K, Jarrin-Franco MC, Lenhard M, Mayerhofer A, Jeschke U.

Int J Mol Sci. 2014 Aug 27;15(9):15161-72. doi: 10.3390/ijms150915161.

Supplemental Content

Loading ...
Support Center